acetyl liposomal glutathione S-Acetyl Relumins Advanced Patented Tri-Form Glutathione

TB-4: Clinical Data for Unrelated Endpoints Meaningful human trial data for full-length TB-4 (corneal-healing Phase 2/3 as RGN-259, plus cardiac and wound-repair programs) Clean Phase 1 safety Cosmetic dosing is extrapolated from these programs Note: Full-length trial data does not transfer to the TB-500 fragment, so verify vial identity

Novo Nordisk A/S: CagriSema demonstrated 23% weight loss in an open-label head-to-head REDEFINE 4 trial in people with obesity, the primary endpoint was not achieved

For many of our patients, these Vitamin injections are an essential component of their daily lives

Potential Benefits of Epitalon Peptide Research into Epitalon peptide therapy continues to evolve

Moreover, some research suggests it might be useful in treatment plans aiming at reducing the cognitive deficits associated with chronic degenerative conditions